Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

By sjmartinez • July 24, 2024

Karpouzas GA, Ormseth SR, van Riel PLCM, Gonzalez-Gay MA, Corrales A, Rantapää-Dahlqvist S, Sfikakis PP, Dessein P, Tsang L, Hitchon C, El-Gabalawy H, Pascual-Ramos V, Contreras-Yáñez I, Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez JR, Semb AG, Misra DP, Hauge EM, Kitas G. Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis. RMD Open. 2024 Jul 23;10(3):e004546. doi: 10.1136/rmdopen-2024-004546. PMID: 39043615.

Tags: Arthritis, biological therapy, cardiovascular diseases, Harbor UCLA, Inflammation, Publications, Rheumatoid, Rheumatology

Layer-specific choroidal vascular adaptation to high-altitude hypoxia revealed by functional OCT at 3,800 m

Safarzadeh MA, Baker JR, Raj SR, Alim U, Day TA, Jendzjowsky NG, Wilson RJA. Layer-specific choroidal vascular adaptation to high-altitude hypoxia revealed by functional OCT[...]

Prognostic Biomarker Signature of Relapse in Neuromyelitis Optica Spectrum Disorders in the CIRCLES Observational Study

Bach E, Breschi A, Wang Y, Carroll MK, Luk W, Han A, Short S, Cimermančič P, Drake KA, Cook LJ, Snyder T, Smith TJ, Yeaman[...]

Colchicine attenuates epicardial adipose tissue progression in stable coronary artery disease: The EKSTROM CT sub-study

Bhandari M, Budoff M, Kinninger A, Narashim A, Condello M, Chandrasekaran A, Lakshmanan S. Colchicine attenuates epicardial adipose tissue progression in stable coronary artery disease:[...]